Pharma Co. CorMedix Faces Investor Suit After Stock Drop
Pharmaceutical company CorMedix allegedly deceived investors about the market potential of its catheter product, causing stock prices to plummet after an article claimed clinical data was overstated and revealed some company...To view the full article, register now.
Already a subscriber? Click here to view full article